Model Medicines
Model Medicines, Inc.
Model Medicines engineers first-in-class small molecules against biological choke points, using AI to advance pipeline-in-a-pill therapeutics across high-impact diseases.
modelmedicines.com · San Diego, CA
Funding event
The round itself, as filedInferred stageSeed
Sold of offered$5.1M of $8.0M
Filed2026-10-21
Days since filing23
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2026-10-15
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Daniel HadersExecutive Officer
Health flags
Three flags, each with the raw inputs behind it · as of 2026-11-13UndersubscribedNot flagged$5.1M of $8.0M sold1 month since first sale
Prior raiseNot flaggedRaised $5.1M against a prior $3.3M$3.3M prior raise, filed 2025-11-14
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-11-010
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-11-15OrcosaSeries A · $6.0M of $11.5M · Ewing, NJQuietChronicleBioPre-seed · $250K of $1.0M · Menlo Park, CAQuiet
103 rounds in Health & bio in the 28 days to 2026-11-12, against 122 in the 28 days before.